Chris Jackson

Cicero Diagnostics, Inc. is an American medical diagnostic company that specializes in unexplained infertility. The private company is based in Henderson, NV. The company is the exclusive licensed provider of the bcl6 test for the detection of uterine lining dysfunction commonly associated with endometriosis. Cicero works with IVF centers across the United States and in 15 other countries. The company continues to expand its offerings and invest in research in the field. Cicero Diagnostics is currently being used at more than 300 infertility centers across the country. The company was founded in 2014 by Chris Jackson, who has been the CEO since then.